Showing results (141-150 of 167) with videos related to
Sort By:
Pageof 17
Hepatology (Baltimore, Md.)|December 9, 2017
Milder disease stage in patients with primary biliary cholangitis over a 44-year period: A changing natural historyCarla F Murillo Perez, Jorn C Goet, Willem J Lammers, et al.Hepatology (Baltimore, Md.)|March 16, 2021
Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naïve Patients With Primary Biliary Cholangitis: A Dual Cut-Off ApproachLaura Cristoferi, Vincenza Calvaruso, Diletta Overi, et al.European Journal of Gastroenterology & Hepatology|December 16, 2020
Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment toolCarla F Murillo Perez, Aliya Gulamhusein, Marco Carbone, et al.Journal of Autoimmunity|September 11, 2022
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitisCumali Efe, Koray Taşçılar, Alessio Gerussi, et al.Journal of Autoimmunity|September 25, 2019
The challenges of primary biliary cholangitis: What is new and what needs to be doneBenedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani, et al.European Journal of Gastroenterology & Hepatology|December 5, 2022
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western EuropeCarla F Murillo Perez, Alessio Gerussi, Palak J Trivedi, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 1, 2025
Clinical Features, Management and Prognosis of Hepatic Sarcoidosis: Insights From a Nationwide Italian StudyCristina Della Corte, Daphne D'Amato, Adele Rocchetti, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 8, 2019
Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary CholangitisAngela C Cheung, Willem J Lammers, Carla F Murillo Perez, et al.Journal of Hepatology|August 22, 2025
Claudin-1 is a mediator and therapeutic target in primary sclerosing cholangitisFabio Del Zompo, Emilie Crouchet, Tessa Ostyn, et al.The American Journal of Gastroenterology|July 4, 2020
Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline PhosphataseCarla F Murillo Perez, Maren H Harms, Keith D Lindor, et al.Pageof 17